Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

68.0K
Overview
68.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

886
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
886

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer.

Nature communications·2026
Same author

Cellular nucleic acid-binding protein (CNBP) dependent cytokine programming shapes host defense against <i>Plasmodium</i> infection.

bioRxiv : the preprint server for biology·2026
Same author

Licensed to pore: Gasdermins in action.

Cell chemical biology·2026
Same author

Editorial Expression of Concern: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation.

Nature immunology·2026
Same author

Lymph node-targeted DNA engages TBK1/IFN-I-driven innate immunity to induce potent T cell responses and durable memory in mice and NHPs.

Science advances·2026
Same author

Endothelial cell expression of STING<sup>V154M</sup>: Gain-of-function mutation delays the resolution of UVB-induced skin injury.

The Journal of investigative dermatology·2026

相关实验视频

Updated: Jun 21, 2025

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

14.5K

揭露免疫抑制

Jason R Pitarresi1, Katherine A Fitzgerald2

  • 1Division of Hematology-Oncology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.

Science (New York, N.Y.)
|July 11, 2024
PubMed
概括

抑制突变的代谢酶可以恢复抗瘤免疫的有效性. 这种方法使免疫系统能够更有效地对抗癌症.

科学领域:

  • 免疫学
  • 代谢途径
  • 癌症研究

背景情况:

  • 癌细胞通常通过改变代谢途径来逃避免疫监测.
  • 突变的代谢酶可以促进瘤生长和免疫抑制.

研究的目的:

  • 调查针对特定突变代谢酶的潜力.
  • 确定抑制这种酶是否可以恢复抗瘤免疫反应.

主要方法:

  • 使用具有特定癌症突变的基因工程小鼠模型.
  • 使用药物抑制剂以向突变的代谢酶.
  • 使用流细胞计和免疫组织化学评估免疫细胞透和瘤内的活性.

主要成果:

  • 抑制突变的代谢酶导致瘤生长显著减少.
  • 在瘤微环境中恢复细胞毒性T淋巴细胞的透和激活.
  • 瘤细胞免疫抑制因子的表达减少.

结论:

  • 针对突变的代谢酶是增强抗瘤免疫力的可行策略.
  • 通过代谢酶抑制可以恢复免疫识别和对癌细胞的攻击.

更多相关视频

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.2K
Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
08:41

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

8.2K

相关实验视频

Last Updated: Jun 21, 2025

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

14.5K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.2K
Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
08:41

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

8.2K